Raymond James & Associates Geron Corp Call Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GERN
# of Institutions
263Shares Held
449MCall Options Held
1.91MPut Options Held
897K-
Black Rock Inc. New York, NY46.6MShares$199 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA46.2MShares$197 Million2.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.9MShares$136 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$116 Million17.06% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y923.9MShares$102 Million12.26% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.61B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...